63 related articles for article (PubMed ID: 2730063)
21. [Value of the assay of plasma carcinoembryonic antigen and thyrocalcitonin in the detection of medullary cancer of the thyroid with amyloid stroma. Results of a familial survey of 47 subjects].
Allanic H
Ann Med Interne (Paris); 1984; 135(5):341-4. PubMed ID: 6486613
[TBL] [Abstract][Full Text] [Related]
22. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
[TBL] [Abstract][Full Text] [Related]
23. C-cell hyperplasia preceding medullary thyroid carcinoma.
Wolfe HJ; Melvin KE; Cervi-Skinner SJ; Saadi AA; Juliar JF; Jackson CE; Tashjian AH
N Engl J Med; 1973 Aug; 289(9):437-41. PubMed ID: 4587234
[No Abstract] [Full Text] [Related]
24. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
Calmettes C; Moudktar MS; Milhaud G
Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
[TBL] [Abstract][Full Text] [Related]
25. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
[TBL] [Abstract][Full Text] [Related]
26. [The C-cell-tumours of the thyroid gland in childhood (author's transl)].
Meybier H; Schmidt-Gayk H; Schütze U
Z Kinderchir; 1982 May; 36(1):30-3. PubMed ID: 7113478
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
29. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
30. [MEN 2A syndrome: report of a family].
Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
[TBL] [Abstract][Full Text] [Related]
31. Increased calcitonin level in thyroid nodules without medullary carcinoma.
Gibelin H; Essique D; Jones C; Levillain P; Maréchaud R; Kraimps JL
Br J Surg; 2005 May; 92(5):574-8. PubMed ID: 15779075
[TBL] [Abstract][Full Text] [Related]
32. [Preventive total thyroidectomy in children with MEN IIa syndrome].
Schmid T; Mühlig HP; Spelsberg F
Chirurg; 1994 Jan; 65(1):48-9. PubMed ID: 7908621
[TBL] [Abstract][Full Text] [Related]
33. The value of intraoperative pentagastrin testing in medullary thyroid cancer.
Scheuba C; Bieglmayer C; Asari R; Kaczirek K; Izay B; Kaserer K; Niederle B
Surgery; 2007 Feb; 141(2):166-71; discussion 171-2. PubMed ID: 17263971
[TBL] [Abstract][Full Text] [Related]
34. A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid.
Hennessy JF; Wells SA; Ontjes DA; Cooper CW
J Clin Endocrinol Metab; 1974 Sep; 39(3):487-95. PubMed ID: 4471967
[No Abstract] [Full Text] [Related]
35. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
[TBL] [Abstract][Full Text] [Related]
36. [Clinical case of the month. Value of a pentagastrin test in the early detection of thyroid medullary cancer].
Legros JJ; Beckers V; Milet J; Denis D; Innocenti C
Rev Med Liege; 1995 Dec; 50(12):499-500. PubMed ID: 8570987
[No Abstract] [Full Text] [Related]
37. The two-mutational-event theory in medullary thyroid cancer.
Jackson CE; Block MA; Greenawald KA; Tashjian AH
Am J Hum Genet; 1979 Nov; 31(6):704-10. PubMed ID: 517520
[TBL] [Abstract][Full Text] [Related]
38. Age-related probability of development of hereditary medullary thyroid carcinoma.
Gagel RF; Jackson CE; Block MA; Feldman ZT; Reichlin S; Hamilton BP; Tashjian AH
J Pediatr; 1982 Dec; 101(6):941-6. PubMed ID: 7143171
[TBL] [Abstract][Full Text] [Related]
39. Management and prevention of familial medullary carcinoma of the thyroid.
Saadi AA
Prog Clin Biol Res; 1979; 34():343-50. PubMed ID: 531059
[No Abstract] [Full Text] [Related]
40. [Thyroid cancer with amyloid stroma. Results of a familial study].
Allannic H; Lorcy Y; Cornec A; Le Marec B; Calmettes C
Ann Endocrinol (Paris); 1979; 40(1):61-2. PubMed ID: 443738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
